Conference abstract
Heterogeneity of abnormal RUNX1 leading to clinicopathological variations in childhood B lymphoblastic leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
RUNX1 gene on Chromosome 21 is frequently aberrant in childhood B-ALL. It is mainly manifested by t(12;21)(p13;q22) resulting in formation of ETV6- RUNX1 fusion gene or amplification of RUNX1 (iAMP21). Although B-ALLs with iAMP21 have more aggressive clinical behavior, the differences of detailed clinicopathologic features resulting from different RUNX1 alterations have not been investigated. This study evaluates how different RUNX1 abnormalities affect the clinicopathology of B-ALL. At Children's Hospital Colorado, 77 cases of B-ALL with iAMP21 (10 cases), ETV6- RUNX1 without RUNX1 gain (33 cases), and ETV6- RUNX1 with RUNX1 gain (34 cases) from 1997-2013 were reviewed. The differences of age, gender, WBC≥50K, CSF+, immunophenotype, blast proliferation rate, and mortality were analyzed. We found that (1) the mean age was older in iAMP group (10.1 years) than that of ETV6-RUNX1 groups (5.1 and 3.5 years with and without RUNX1 gain respectively, p=0.0001), suggesting that the factors driving RUNX1 amplification may require longer time to develop or operate than those driving RUNX1 translocation; (2) CD7 frequently expressed in iAMP21group (56%), but never expressed in ETV6- RUNX1 groups (p=0.0001), suggesting that RUNX1 amplification may prevent silencing of T-cell phenotype in B-lymphoblasts; (3) CD13 often expressed in patients with ETV6-RUNX1 (55% and 25% with and without RUNX1 gain respectively), but never expressed in iAMP group (p=0.0265), suggesting that RUNX1 at 21q22 likely is a myeloid associated breakpoint as seen in AML with t(8;21)(q22;q22)/ RUNX1 - RUNX1 T1; and (4) there was no significant difference between ETV6-RUNX1 with RUNX1 gain and without RUNX1 gain groups.
Keywords
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood Disorders & Transfusion
- SubjectHaematology
- BylineArticles whose byline prints “Xiayuan Liang”